Exane Derivatives’s Goldcorp Inc GG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-122,575
| Closed | -$1.4M | – | 755 |
|
|
2019
Q1 | $1.4M | Sell |
122,575
-313,189
| -72% | -$3.36M | 0.28% | 86 |
|
|
2018
Q4 | $4.27M | Buy |
435,764
+320,466
| +278% | +$3.11M | 0.77% | 27 |
|
|
2018
Q3 | $1.18M | Buy |
115,298
+57,818
| +101% | +$678K | 0.22% | 101 |
|
|
2018
Q2 | $788K | Buy |
57,480
+7,914
| +16% | +$110K | 0.13% | 139 |
|
|
2018
Q1 | $669K | Sell |
49,566
-114,407
| -70% | -$1.55M | 0.13% | 148 |
|
|
2017
Q4 | $2.09M | Buy |
163,973
+55,476
| +51% | +$717K | 0.36% | 47 |
|
|
2017
Q3 | $1.41M | Sell |
108,497
-1,182
| -1% | -$15.5K | 0.26% | 71 |
|
|
2017
Q2 | $1.42M | Buy |
109,679
+11,532
| +12% | +$161K | 0.3% | 75 |
|
|
2017
Q1 | $1.43M | Buy |
98,147
+6,157
| +7% | +$96.2K | 0.32% | 73 |
|
|
2016
Q4 | $1.25M | Buy |
91,990
+57,939
| +170% | +$807K | 0.25% | 78 |
|
|
2016
Q3 | $562K | Buy |
34,051
+3,797
| +13% | +$66.9K | 0.08% | 146 |
|
|
2016
Q2 | $579K | Sell |
30,254
-78,907
| -72% | -$1.4M | 0.1% | 122 |
|
|
2016
Q1 | $1.77M | Buy |
109,161
+53,814
| +97% | +$748K | 0.24% | 61 |
|
|
2015
Q4 | $640K | Buy |
55,347
+55,235
| +49,317% | +$703K | 0.09% | 103 |
|
|
2015
Q3 | $1.4K | Sell |
112
-34,981
| -100% | -$489K | ﹤0.01% | 414 |
|
|
2015
Q2 | $568K | Sell |
35,093
-8,133
| -19% | -$148K | 0.06% | 134 |
|
|
2015
Q1 | $783K | Sell |
43,226
-114
| -0.3% | -$2.43K | 0.09% | 110 |
|
|
2014
Q4 | $803K | Buy |
+43,340
| New | +$889K | 0.11% | 112 |
|
Other funds holding GG
Exane Derivatives's GG Position: Q2 2019 in Review
Exane Derivatives sold out of Goldcorp Inc (GG) in Q2 2019, closing a stake of 122,575 shares — an estimated $1.4M sold.
Exane Derivatives first reported a position in GG in Q4 2014 and held it in 18 quarters. The position peaked at $4.27M in Q4 2018. 2 funds tracked by Wall St. Rank hold GG as of Q2 2019.
- Exane Derivatives reported no remaining Goldcorp Inc position as of Q2 2019 after selling out during the quarter.
- Exane Derivatives sold 122,575 Goldcorp Inc shares in Q2 2019, an estimated $1.4M.
- Exane Derivatives first reported a position in Goldcorp Inc in Q4 2014 and held it in 18 quarters.
- Exane Derivatives's Goldcorp Inc position peaked at $4.27M in Q4 2018.
- 2 funds tracked by Wall St. Rank held Goldcorp Inc as of Q2 2019.
Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.